Edition:
India

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

49.67USD
12:26am IST
Change (% chg)

$0.86 (+1.75%)
Prev Close
$48.82
Open
$49.04
Day's High
$49.85
Day's Low
$48.98
Volume
988,673
Avg. Vol
1,800,387
52-wk High
$51.12
52-wk Low
$37.38

ABT.N

Chart for ABT.N

About

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $84,821.98
Shares Outstanding(Mil.): 1,737.44
Dividend: 0.26
Yield (%): 2.17

Financials

  ABT.N Industry Sector
P/E (TTM): 74.96 30.33 31.72
EPS (TTM): 0.65 -- --
ROI: 2.24 14.43 13.98
ROE: 4.07 15.52 15.32

BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories ​

* Enzo Biochem says ‍a federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences, Inc. v. Abbott Laboratories - sec filing​

16 Aug 2017

BRIEF-Abbott Laboratories says co & North West London Pathology signed a $252 mln managed equipment services contract

* Abbott Laboratories- Co & North West London Pathology signed a $252 million managed equipment services contract

15 Aug 2017

BRIEF-Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere Inc

* Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere Inc

14 Aug 2017

BRIEF-Roxwood Medical enters into an exclusive agreement with Abbott for distribution of roxwood products in United States

* Roxwood Medical - entered into an exclusive agreement with Abbott for distribution of Roxwood Products in United States Source text for Eikon: Further company coverage:

25 Jul 2017

BRIEF-Alere Inc enters into purchase agreement with Siemens Diagnostics ​‍​

* Says ‍on July 21, 2017, Alere entered into purchase agreement with Siemens Diagnostics Holding II B.V. ​‍​

21 Jul 2017

UPDATE 1-Abbott raises full-year profit forecast

July 20 Abbott Laboratories on Thursday raised its full-year adjusted profit forecast as the diversified healthcare company gains from its $25 billion acquisition of St. Jude Medical.

20 Jul 2017

Abbott's quarterly profit halves as costs soar

July 20 Diversified healthcare company Abbott Laboratories reported a 55 percent drop in quarterly profit on Thursday, hurt by higher costs.

20 Jul 2017

BRIEF-Abbott says commences tender offer for Series B preferred stock of Alere

* Abbott commences cash tender offer for all outstanding shares of series b convertible perpetual preferred stock of Alere Inc

17 Jul 2017

BRIEF-Abbott, Bigfoot Biomedical enter deal to develop diabetes management systems

* Abbott Laboratories and Bigfoot Biomedical enter agreement to develop and commercialize diabetes management systems

13 Jul 2017

BRIEF-Alere shareholders approve amended merger with Abbott

* Alere says about 63 million of votes cast at special meeting voted in favor of amended merger, representing over 72.5 percent of alere shares as of may 31 Source text for Eikon: Further company coverage:

08 Jul 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $134.31 +0.93
Pfizer Inc. (PFE.N) $33.29 -0.09
Novartis AG (NOVN.S) CHF81.95 +0.35
Merck & Co., Inc. (MRK.N) $62.62 +0.12
Sanofi SA (SASY.PA) €82.58 +0.81
AstraZeneca plc (AZN.L) 4,467.50 +11.00
GlaxoSmithKline plc (GSK.L) 1,504.00 +9.50
Eli Lilly and Co (LLY.N) $80.89 -0.82
Amgen, Inc. (AMGN.OQ) $171.42 +1.38
Boston Scientific Corporation (BSX.N) $26.65 +0.18

Earnings vs. Estimates